期刊文献+

纳米微球增强免疫比浊法测定胱抑素C 被引量:3

下载PDF
导出
摘要 目的建立纳米微球增强免疫比浊测定血清胱抑素C(Cys C)的全自动分析法。方法用纳米微球增强免疫比浊测定Cys C,并对方法进行精密度、线性、准确性等评价及临床初步应用探讨。结果此方法批内CV<40%,批间CV<5.0%。抗干扰性强,4.0 g/L血红蛋白、420μmol/L胆红素、2 200 IU/L类风湿因子、10 mmol/L三酰甘油对测定无影响;与进口试剂相关性良好(r=0.999 5)。试剂开瓶稳定性良好。结论纳米微球增强免疫比浊法测定血清Cys C,具有方法简便、快速、灵敏的优点,且结果准确,可用自动分析仪测试,适合临床检验应用。
出处 《国际检验医学杂志》 CAS 2011年第3期389-390,共2页 International Journal of Laboratory Medicine
基金 温州市龙湾区科技发展计划项目(2008S6Z)
  • 相关文献

参考文献7

  • 1Michele M, Nicoletta R, Mariacristina V, et al. Quantitative auto mated particle enhanced immunonephelometric assay for the routinary measurement of human cystatin[J]. Clin Lab Med, 1998,36 (11):859-865.
  • 2Tian S,Kusano E,Ohara T,et al. Cystatin C measurement and its practical use in patients with various renal diseases[J]. Clin Neph rol, 1997,48(2) : 104-108.
  • 3刘航,陈香美.胱蛋白酶抑制剂C与肾脏[J].中国实验诊断学,2001,5(4):151-153. 被引量:24
  • 4K yhse-Andersen J,Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method,is a better marker than serum creatinine for glomerular filtration rate[J]. Clin Chem, 1994,40(10):1921-1926.
  • 5Finney H, Newman DJ,Gruber W, et al. Initial evaluation of eys tatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II) [J]. Clin Chem,1997,43(6 Pt 1):1016-1022.
  • 6任爱英,王凡.血清胱抑素C的临床应用及研究[J].检验医学与临床,2008,5(1):32-34. 被引量:45
  • 7冯仁丰,主编,临床检验质量管理技术基础[M].上海:上海科学技术文献出版社,2004.243.

二级参考文献22

  • 1[1]Fanos V, Mussap M, Plebani M, et al. Cystatin C in pediatric: Present situation and prospect[J]. Minerva Pediatr, 1999,51(5): 167.
  • 2[2]Randers E, Erlandsen EJ . Serum cystatin C as an endogenous marker of the reanl function-a review[J]. Clin Chem Lab Med, 1999, 37(4):389.
  • 3[3]Keevil BG, Kilpatrick ES, Nichols SP, et al. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate[J]. Clin Chem, 1998, 44(7):1535.
  • 4[4]Bokenkamp A, Domanertzki M, Zinck R, et al. Reference values for cystatin C serum concentration in children[J]. Padiatr Nephrol, 1998,12(2): 125.
  • 5[5]Tian S, Kusano E, Ohara T, et al. Cystatin C measurement and its practical use in patients with various renal diseases[J]. Clin Nephrol,1997, 48(2): 104.
  • 6[6]Fliser D, Ritz E. Serum cystatin C concertration as a marker of renal dysfunction in the elderly[J]. Am J Kidney Dis ,2001, 37(1) :79.
  • 7[7]Mojimintyi OA, Abdella N, George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus[J]. Scand J Clin Lab Invest ,2000, 60(6) :483.
  • 8[8]Chantrel F, Agin A, Offner M et al. Comparison of cystatin C versus creatinine for detection of mild renal failure[J]. Oin Nephrol ,2000,54(5): 374.
  • 9[9]Hamoinen A, Ylinen E, Ala-Houhala M, et al. Reference intervals for cystatin C in pre-and full-temm infants and children [J ]. Padiatr Nephrol, 2000, 15(1-2): 105.
  • 10[10]Randers E, Erlandsen EJ, Pedersen OL, et al. Serum cystatin C as an endogenous paramenter of the renal function in patients with norral to moderately impairde kidney function[J]. Clin Nephrol,2000, 54(3):203.

共引文献90

同被引文献17

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部